Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

8th FENS Forum of Neuroscience
Teva announces FDA acceptance of sNDA for a higher concentration dose of COPAXONE® given three times a week
Copolymer 1 inhibits manifestations of graft rejection.
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.
Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis.
A molecular link between the active component of marijuana and Alzheimer's disease pathology.
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
New data analyses show significant clinical and MRI improvements with PLEGRIDY™ (peginterferon beta-1a)
Roche reports positive studies of MabThera given by subcutaneous injection
Changes to anti-JCV antibody levels in a Swedish national MS cohort.
Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS.
Benefit of Endermology on Indurations and Panniculitis/Lipoatrophy During Relapsing-Remitting Multiple Sclerosis Long-Term Treatment with Glatiramer Acetate.
A promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitis.
The mystery of missing heritability: Genetic interactions create phantom heritability.
Ustekinumab.
Assessment of statistical significance and clinical relevance.
Takeda Submits a New Drug Application for Glatiramer Acetate in Japan for the Relapse Prevention of Multiple Sclerosis
Effectiveness of glatiramer acetate compared to other multiple sclerosis therapies.
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench.
Assessment of Disease Activity in Multiple Sclerosis Phenotypes with Combined Gadolinium- and Superparamagnetic Iron Oxide-enhanced MR Imaging.
Disrupted balance of T cells under natalizumab treatment in multiple sclerosis.
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.
PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms.

Pages